Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
LivaNova PLC (DE:LIA)
FRANKFURT:LIA
Holding DE:LIA?
Track your performance easily
LIA Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€39.00 - €59.00
Previous Close€47.6
Volume0.00
Average Volume (3M)175.00
Market Cap
€2.63B
Enterprise Value€2.94B
Total Cash (Recent Filing)$329.24M
Total Debt (Recent Filing)$668.69M
Price to Earnings (P/E)―
Beta0.56
Next Earnings
Oct 30, 2024EPS Estimate
€0.65Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding54,297,960
10 Day Avg. Volume0
30 Day Avg. Volume175
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)2.08
Price to Sales (P/S)2.39
Price to Cash Flow (P/CF)16.70
P/FCF Ratio23.20
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.43
Enterprise Value/Gross Profit3.81
Enterprise Value/Ebitda129.10
Forecast
1Y Price Target
€63.98Price Target Upside34.41% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7
LivaNova News
PremiumCompany Announcements
LivaNova Announces CHRO Hebbelinck’s Planned Departure and Benefits
Bulls Say, Bears Say
Bulls Say
Growth DriversThe company is entering a period with clear and more visible baseline growth drivers, augmented by potential revenue and EPS upside from new product cycles and pipeline optionality.
Management GuidanceManagement raised FY24 revenue/EPS guidance, and ongoing HLM strength is expected to continue.
Reimbursement TailwindA meaningful increase to VNS reimbursement (if enacted) at face value should be a tailwind.
Bears Say
EarningsStrategic shifts in the business and pipeline setbacks have put downward pressure on earnings and the stock's P/E multiple.
Financial PerformancePotential payout of the $490M SNIA liability appears to represent an incremental $0.40-0.50 headwind as the cash reduction, coupled with existing debt, will lower LivaNova's interest income.
Legal IssuesLIVN still has to contend with Italian litigation overhangs.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.33% Insiders
27.54% Mutual Funds
0.08% Other Institutional Investors
53.91% Public Companies and
Individual Investors
LIA FAQ
What was LivaNova PLC’s price range in the past 12 months?
LivaNova PLC lowest stock price was €39.00 and its highest was €59.00 in the past 12 months.
What is LivaNova PLC’s market cap?
Currently, no data Available
When is LivaNova PLC’s upcoming earnings report date?
LivaNova PLC’s upcoming earnings report date is Oct 30, 2024 which is in 24 days.
How were LivaNova PLC’s earnings last quarter?
LivaNova PLC released its earnings results on Jul 31, 2024. The company reported €0.84 earnings per share for the quarter, beating the consensus estimate of €0.707 by €0.133.
Is LivaNova PLC overvalued?
According to Wall Street analysts LivaNova PLC’s price is currently Undervalued.
Does LivaNova PLC pay dividends?
LivaNova PLC does not currently pay dividends.
What is LivaNova PLC’s EPS estimate?
LivaNova PLC’s EPS estimate is €0.65.
How many shares outstanding does LivaNova PLC have?
LivaNova PLC has 54,297,960 shares outstanding.
What happened to LivaNova PLC’s price movement after its last earnings report?
LivaNova PLC reported an EPS of €0.84 in its last earnings report, beating expectations of €0.707. Following the earnings report the stock price went down -1.681%.
Which hedge fund is a major shareholder of LivaNova PLC?
Among the largest hedge funds holding LivaNova PLC’s share is PRIMECAP Management Co. It holds LivaNova PLC’s shares valued at 328M.
---
LivaNova Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€63.98 (34.41% Upside)
€63.98 (34.41% Upside)
Blogger Sentiment
Neutral
DE:LIA Sentiment 50%
Sector Average 70%
Sector Average 70%
Insider Transactions
Sold Shares
Worth $69.9K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
4.26%
12-Months-Change
Fundamentals
Return on Equity
-1.34%
Trailing 12-Months
Asset Growth
4.77%
Trailing 12-Months
Company Description
LivaNova PLC
LivaNova Plc is a global medical technology company, which engages in the development and delivery of important therapeutic solutions for the benefit of patients, healthcare professionals and healthcare systems. It operates through the following segments: Cardiovascular, Neuromodulation, and Others. The Cardiovascular segment develops, produces, and sells cardiopulmonary products, heart valves, and advanced circulatory support products. The Neuromodulation segment designs and markets NM-based medical devices for the treatment of epilepsy, depression, and obstructive sleep apnea. The Other segment consists of company's shared service expenses for finance, legal, human resources, information technology, and new ventures. Its products include VNS therapy system. oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, and cannulae. The company was founded on February 20, 2015 and is headquartered in London, the United Kingdom.
---
LIA Company Deck
---
LIA Earnings Call
Q2 2024
0:00 / 0:00
---
LIA Stock 12 Month Forecast
Average Price Target
€63.98
▲(34.41% Upside)
Technical Analysis
Best Analysts Covering LIA
1 Year
1 Year Success Rate
10/21 ratings generated profit
1 Year Average Return
-4.09%
reiterated a buy rating 2 months ago
Copying Michael Matson's trades and holding each position for 1 Year would result in 47.62% of your transactions generating a profit, with an average return of -4.09% per trade.
---